Literature DB >> 2350904

Hyponatremia and hypouricemia: differentiation from SIADH.

J K Maesaka1, V Batuman, M Yudd, M Salem, A F Sved, J Venkatesan.   

Abstract

Hypouricemia in coexistence with hyponatremia often differentiates the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) from most other causes of hyponatremia. We report clearance studies in 5 cases of hyponatremia and hypouricemia that were not due to SIADH. One had metastatic pancreatic carcinoma with ascites, edema, hypoalbuminemia and hypophosphatemia. Two had adenocarcinoma of the lung with metastasis to the brain in 1, 1 had disseminated cryptococcus and 1 had Hodgkin's disease. None received radiation or known nephrotoxins at least 4 months prior to study. None had serum creatinine greater than 106.1 mumol/l (1.2 mg/dl). Two had postural hypotension and hyponatremia that responded to saline therapy. Fluid restriction corrected the hyponatremia in all patients, but the hypouricemia, high fractional excretion (FE) of urate, and high urine sodium concentration persisted. In 2 patients studied, ADH was appropriately suppressed after volume repletion but there was a defect in free water clearance due to high renal solute excretion. In contrast to patients with SIADH who correct their defect in renal urate transport with correction of hyponatremia by water restriction, our patients appear to have a persistent renal urate transport defect and abnormality in sodium conservation. Elevated FE urate of greater than 10% after correction of hyponatremia can thus differentiate these patients from SIADH. The diametrically opposing goals of fluid therapy emphasize the importance of differentiating one group from the other.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350904

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

Review 1.  Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.

Authors:  A Mancini; R Festa; V Di Donna; E Leone; G P Littarru; A Silvestrini; E Meucci; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

2.  More on renal salt wasting without cerebral disease: response to saline infusion.

Authors:  Solomon Bitew; Louis Imbriano; Nobuyuki Miyawaki; Steven Fishbane; John K Maesaka
Journal:  Clin J Am Soc Nephrol       Date:  2009-02       Impact factor: 8.237

3.  Demonstration of natriuretic activity in urine of neurosurgical patients with renal salt wasting.

Authors:  Steven J Youmans; Miriam R Fein; Elizabeth Wirkowski; John K Maesaka
Journal:  F1000Res       Date:  2013-05-10

4.  Application of established pathophysiologic processes brings greater clarity to diagnosis and treatment of hyponatremia.

Authors:  John K Maesaka; Louis J Imbriano; Nobuyuki Miyawaki
Journal:  World J Nephrol       Date:  2017-03-06

Review 5.  Hyponatremia in the elderly: challenges and solutions.

Authors:  Theodosios D Filippatos; Andromachi Makri; Moses S Elisaf; George Liamis
Journal:  Clin Interv Aging       Date:  2017-11-14       Impact factor: 4.458

6.  Determining Fractional Urate Excretion Rates in Hyponatremic Conditions and Improved Methods to Distinguish Cerebral/Renal Salt Wasting From the Syndrome of Inappropriate Secretion of Antidiuretic Hormone.

Authors:  John K Maesaka; Louis J Imbriano; Nobuyuki Miyawaki
Journal:  Front Med (Lausanne)       Date:  2018-11-30

Review 7.  Differentiating SIADH from Cerebral/Renal Salt Wasting: Failure of the Volume Approach and Need for a New Approach to Hyponatremia.

Authors:  John K Maesaka; Louis Imbriano; Joseph Mattana; Dympna Gallagher; Naveen Bade; Sairah Sharif
Journal:  J Clin Med       Date:  2014-12-08       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.